1054 related articles for article (PubMed ID: 20812792)
1. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
Roth T; van Seventer R; Murphy TK
Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
4. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
Vinik A; Emir B; Cheung R; Whalen E
Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
[TBL] [Abstract][Full Text] [Related]
5. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
Sharma U; Griesing T; Emir B; Young JP
Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
Baron R; Brunnmüller U; Brasser M; May M; Binder A
Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
8. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
Vinik A; Emir B; Parsons B; Cheung R
Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
11. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
[TBL] [Abstract][Full Text] [Related]
12. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
[TBL] [Abstract][Full Text] [Related]
13. [Pregabalin in the treatment of neuropathic pain].
Biegstraaten M; van Schaik IN
Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1561-5. PubMed ID: 17715763
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
[TBL] [Abstract][Full Text] [Related]
15. Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia.
Parsons B; Emir B; Knapp L
Am J Ther; 2015; 22(4):257-68. PubMed ID: 25272094
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
[TBL] [Abstract][Full Text] [Related]
17. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
18. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
Gilron I; Wajsbrot D; Therrien F; Lemay J
Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin for neuropathic pain in adults.
Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]